BOT 1.54% 32.0¢ botanix pharmaceuticals ltd

LEAD PRODUCT: BTX 1503 (MODERATE TO SEVERE ACNE) - Phase 2 clinical trial, page-18

  1. 790 Posts.
    lightbulb Created with Sketch. 141
    Consider OPT and the jump it had post successful phase 2 trial...there is no reason that bot couldn't do the same. Similar MC.

    One could certainly argue that bot has a much superior market opportunity in acne should the drug btx1503 be shown to be effective...nevermind the other drugs in the pipeline.

 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
32.0¢
Change
-0.005(1.54%)
Mkt cap ! $581.5M
Open High Low Value Volume
32.5¢ 33.0¢ 32.0¢ $1.058M 3.280M

Buyers (Bids)

No. Vol. Price($)
2 147750 32.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.5¢ 632850 6
View Market Depth
Last trade - 16.10pm 13/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.